Expertise in
10
conditions

Hiroshi Nakajima

Chiba, JP 
Expertise in
10
conditions
Chiba, JP 

Overview

Hiroshi Nakajima practices practicing medicine in Chiba, Japan.

Mr. Nakajima is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Kimura Disease, Synovitis, Rheumatoid Arthritis (RA), and Pneumomediastinum.

He is actively involved in clinical research, co-authoring 186 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Chiba, Japan
Other Locations
Sakado, 3500283, Japan
Chuo, Japan
Yushima, 1138510, Japan
Saitama, Japan
Atsugi, 2430014, Japan
St. Marianna University School of Medicine
Kawasaki, Japan
Chiyoda, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial
Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial
Enrollment Status: Unknown
Publish Date: January 27, 2021
Intervention Type: Drug
Study Drugs: Rituximab, Glucocorticoids
Study Phase: Phase 4

186 Total Publications

Low-dose atovaquone for prophylaxis of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases: an open-label, multicentre, single-arm, phase II trial.
Low-dose atovaquone for prophylaxis of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases: an open-label, multicentre, single-arm, phase II trial.
Journal: EULAR rheumatology open
Published: June 29, 2026

Frequently Asked Questions about Hiroshi Nakajima

Is Hiroshi Nakajima a top-rated expert for Kimura Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Hiroshi Nakajima is classified as an Advanced expert for Kimura Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hiroshi Nakajima participate in research or clinical trials?

Yes. Hiroshi Nakajima has published 186 articles and abstracts on conditions like Kimura Disease. You can view a list of Hiroshi Nakajima's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nakajima's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 35 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile